Statistical media optimization for the production of clinical uricase from Bacillus subtilis strain SP6

Enhancing stability and catalytic activity of urate oxidase using natural deep eutectic solvent: insights from experimental and computational approaches

This study investigated the impact of natural deep eutectic solvents (DES) based on sucrose, fructose and glycerol on the recombinant uricase enzyme. The plasmid recombinant pET-28a+ containing uricase coding sequence was extracted from the DH5α strain and transferred into the BL21 expration strain. Subsequently, overnight culture, induction with IPTG, and purification of the recombinant uricase using Ni-NTA affinity chromatography methods were carried out. The effect of DES containing sucrose, fructose and glycerol was assessed and 5% DES concentration verified for subsequent experiment. Thermodynamic parameters were analyzed using thermal inactivation and intrinsic fluorescence methods at temperatures of 35, 45, 55, and 65 °C. The results demonstrated lengthened enzyme half-life by approximately 61 min, higher activation energy and Tm, indicating improved thermal stability compared to the free enzyme. Kinetic tests revealed a reduction in the km value from 0.16 mM in the free enzyme to 0.09 mM in the treated enzyme, suggesting enhanced substrate binding affinity. Moreover, the Kcat/Km ratio, reflecting enzyme specificity towards the substrate, was enhanced. In the molecular dynamics simulation section, the root mean square deviation (RMSD), root mean square fluctuation (RMSF), and solvent accessible surface area (SASA) were analyzed. Lower RMSD and RMSF values indicate that the structure is more stable in the presence of the eutectic solvent compared to the free enzyme.

Isolation and Characterization of Highly Active Uricase from Alcaligenes spp. Strain UR1

For the first time, this study reports extracellular uricase enzyme isolation and characterization from strain UR1 of Alcaligenes spp. from Western Saudi Arabia. The strain efficiently produced highly active extracellular uricase for therapeutic applications. It offers a simplified enzyme purification approach rather than complicated intracellular enzyme purification from other microbes. Strain UR1 exhibited significantly higher uricase synthesis potential [916 U/mg (specific activities) and 275 U/ml (volume)]. The study optimized the conditions (37°C and pH 7.4) for 10% enhanced uricase production in the BT medium where sucrose served as the carbon source. Uricase enzyme remained stable at various pH levels (5-9) up to 50°C, however, the optimal activity was noted at 40°C and pH 7.5. The strain was sensitive to EDTA-like inhibitors. Ca2+ improved the strain activity, which could yield potent formulations for clinical and industrial applications. This novel aspect presents Alcaligenes spp. strain UR1 as a promising candidate for the treatment of hyperuricemia and gout. It offers an efficient and inexpensive alternative for uricase synthesis at the industrial scale. These findings encourage further investigations regarding genetic aspects of uricase for improved bioprocessing and therapeutic applications.

Maximization of uricase production in a column bioreactor through response surface methodology-based optimization

Uricase (EC 1.7.3.3) is an oxidoreductase enzyme that is widely exploited for diagnostic and treatment purposes in medicine. This study focuses on producing recombinant uricase fromE. coliBL21 in a bubble column bioreactor (BCB) and finding the optimal conditions for maximum uricase activity. The three most effective variables on uricase activity were selected through the Plackett-Burman design from eight different variables and were further optimized by the central composite design of the response surface methodology (RSM). The selected variables included the inoculum size (%v/v), isopropylβ-d-1-thiogalactopyranoside (IPTG) concentration (mM) and the initial pH of the culture medium. The activity of uricase, the final optical density at 600 nm wavelength (OD600) and the final pH were considered as the responses of this optimization and were modeled. As a result, activity of 5.84 U·ml-1and a final OD600of 3.42 were obtained at optimum conditions of 3% v/v inoculum size, an IPTG concentration of 0.54 mM and a pH of 6.0. By purifying the obtained enzyme using a Ni-NTA agarose affinity chromatography column, 165 ± 1.5 mg uricase was obtained from a 600 ml cell culture. The results of this study show that BCBs can be a highly effective option for large-scale uricase production.

Optimization of industrial (3000 L) production of Bacillus subtilis CW-S and its novel application for minituber and industrial-grade potato cultivation

A commercial plant probiotic product was developed employing Bacillus subtilis CW-S in submerged fermentation. The effects of molasses and urea on cell growth were investigated with the goal of low-cost manufacturing. Plackett–Burman and Central-Composite Design (CCD) were utilized to optimize production parameters to maximize productivity. The stability of the formulated product and its efficacy in cultivating minituber in aeroponics and industrial-grade potatoes in the field were assessed. The results showed that the medium BS10 (molasses and urea) produced satisfactory cell density (7.19 × 10⁸ CFU/mL) as compared to the control (1.51 × 10⁷ CFU/mL) and BS1-BS9 (expensive) media (1.84 × 10⁷–1.37 × 10⁹ CFU/mL). According to validated CCD results, optimized parameters fitted well in pilot (300 L; 2.05 × 10⁹ CFU/mL) and industrial (3000 L; 2.01 × 10⁹ CFU/mL) bioreactors, resulting in a two-fold increase in cell concentration over laboratory (9.84 × 10⁸ CFU/mL) bioreactors. In aeroponics, CW-S produced excellent results, with a significant increase in the quantity and weight of minitubers and the survival rate of transplanted plantlets. In a field test, the yield of industrial-grade (> 55 mm) potatoes was increased with a reduction in fertilizer dose. Overall, the findings suggest that CW-S can be produced commercially utilizing the newly developed media and optimized conditions, making plant probiotics more cost-effective and accessible to farmers for crop cultivation, particularly in aeroponic minituber and industrial-grade potato production.

Optimized UV-Spectrophotometric Assay to Screen Bacterial Uricase Activity Using Whole Cell Suspension

Uricase catalyzes the conversion of uric acid into allantoin with concomitant reduction of molecular oxygen to hydrogen peroxide. In humans, uricase is not functional, thereby predisposing individuals to hyperuricemia, a metabolic disturbance associated with gout, chronic kidney disorders, and cardiovascular diseases. The efficacy of current therapies to treat hyperuricemia is limited, and novel approaches are therefore desired, for instance using uricase-expressing probiotic strains. Here, we evaluated UV-spectrophotometric and H₂O₂-based fluorescent assays to enable the rapid identification of uricase activity in a broad panel of lactobacilli, Bacillus, and Bifidobacterium species. We highlighted abiotic (medium composition and mode of sterilization) and biotic (H₂O₂-producing strains) factors impacting the measurements' accuracy, and reported on the stepwise optimization of a simple, fast, and robust high-throughput UV-spectrophotometric method to screen uricase activity using whole bacterial suspension, thereby assessing both cell-associated and extracellular activity. The validity of the optimized assay, based on the monitoring of uric acid degradation at 300 nm, was confirmed via liquid chromatography. Finally, a panel of 319 Qualified Presumption of Safety (QPS) strains of lactobacilli (18 species covering nine genera), Bacillus (three species), and Bifidobacterium (four species) were screened for uricase activity using the optimized method. All 319 strains, but the positive control Bacillus sp. DSM 1306, were uricase-negative, indicating that this activity is rare among these genera, especially in isolates from food or feces. Altogether, the UV-spectrophotometric high-throughput assay based on whole bacterial suspension reported here can be used to rapidly screen large microbial collections, by simultaneously detecting cell-associated and extracellular uricase activity, thereby accelerating the identification of uricolytic strains with therapeutic potential to treat hyperuricemia.